Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 26;13(1):4931.
doi: 10.1038/s41598-023-32171-w.

Prognostic nomogram and risk factors for predicting survival in patients with pT2N0M0 esophageal squamous carcinoma

Affiliations
Review

Prognostic nomogram and risk factors for predicting survival in patients with pT2N0M0 esophageal squamous carcinoma

Mei Kang et al. Sci Rep. .

Abstract

This study analyzed the impact of factors affecting overall survival in patients with pT2N0M0 esophageal squamous carcinoma (ESCC) and developed a nomogram to predict overall survival (OS). We reviewed the clinical data of 413 patients with pathological T2N0M0 ESCC after radical esophagectomy in two hospitals. Data from one institution was used as the training cohort. A nomogram was established using Cox proportional hazard regression for identifying the prognostic factors affecting for OS in ESCC patients. The area under the curve (AUC), calibration curves and decision curve analysis (DCA) were used to evaluate prognostic efficacy, which was validated in an independent validation cohort. In the training cohort (N = 304), the median OS was 69.33 months, and the 3-, 5- and 10-year OS rates were 76.80%, 67.00% and 56.90%, respectively. The median OS of the validation cohort (N = 109) was 73.50 months, and the 3-, 5- and 10-year OS rates were 77.00%, 67.80% and 55.60%, respectively. According to Cox univariate and multivariate analyses, sex, age, tumor length and the number of resected lymph nodes were identified as predictors of OS. We developed nomograms and performed internal and external validation. The time-dependent receiver operating characteristic (ROC) curve and area under the curve (AUC) value, calibration curve and decision curve analysis (DCA) showed good prediction ability of the nomogram. The developed nomogram can effectively predict OS after esophagectomy in patients with pT2N0M0 ESCC.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Kaplan–Meier curves for the OS of the training cohort. Age group (A), sex group (B), length group (C), lymph node metastasis (LNM) group (D).
Figure 2
Figure 2
Nomogram predicting the 3-,5- and 10-year OS rates from the training cohort.
Figure 3
Figure 3
(A) ROC curves for 3-, 5-, and 10-year OS based on the nomogram for the training cohort. (B) Calibration curve of predicted 3-year OS. (C) Calibration curve of the predicted 5-year OS. (D) Calibration curve of the predicted 10-year OS.
Figure 4
Figure 4
(A) ROC curves for 3-, 5-, and 10-year OS based on the nomogram for the validation cohort. (B) Time-dependent AUC curve showing the performance of the nomogram in predicting OS in the validation cohort. (C) Calibration curve of the predicted 3-year OS. (D) Decision curve analysis for 3-year OS.

Similar articles

Cited by

References

    1. Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Morgan E, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: New estimates from GLOBOCAN 2020. Gastroenterology. 2022;163:649–658.e642. doi: 10.1053/j.gastro.2022.05.054. - DOI - PubMed
    1. Allemani C, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–1075. doi: 10.1016/s0140-6736(17)33326-3. - DOI - PMC - PubMed
    1. Mariette C, et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer. 2003;97:1616–1623. doi: 10.1002/cncr.11228. - DOI - PubMed
    1. Hou X, et al. The impact of tumor cell differentiation on survival of patients with resectable esophageal squamous cell carcinomas. Ann. Surg. Oncol. 2015;22:1008–1014. doi: 10.1245/s10434-014-4067-x. - DOI - PubMed

Publication types